title: Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function.
abstract: Multiple independent mutations in neuroligin genes were identified in patients with familial autism, including the R451C substitution in neuroligin-3 (NL3). Previous studies showed that NL3(R451C) knock-in mice exhibited modestly impaired social behaviors, enhanced water maze learning abilities, and increased synaptic inhibition in the somatosensory cortex, and they suggested that the behavioral changes in these mice may be caused by a general shift of synaptic transmission to inhibition. Here, we confirm that NL3(R451C) mutant mice behaviorally exhibit social interaction deficits and electrophysiologically display increased synaptic inhibition in the somatosensory cortex. Unexpectedly, however, we find that the NL3(R451C) mutation produced a strikingly different phenotype in the hippocampus. Specifically, in the hippocampal CA1 region, the NL3(R451C) mutation caused an ∼1.5-fold increase in AMPA receptor-mediated excitatory synaptic transmission, dramatically altered the kinetics of NMDA receptor-mediated synaptic responses, induced an approximately twofold up-regulation of NMDA receptors containing NR2B subunits, and enhanced long-term potentiation almost twofold. NL3 KO mice did not exhibit any of these changes. Quantitative light microscopy and EM revealed that the NL3(R451C) mutation increased dendritic branching and altered the structure of synapses in the stratum radiatum of the hippocampus. Thus, in NL3(R451C) mutant mice, a single point mutation in a synaptic cell adhesion molecule causes context-dependent changes in synaptic transmission; these changes are consistent with the broad impact of this mutation on murine and human behaviors, suggesting that NL3 controls excitatory and inhibitory synapse properties in a region- and circuit-specific manner.
authors.affiliation: Department of Molecular and Cellular Physiology, Stanford University Medical School, Stanford, CA 94305, USA.
authors.forename: Mark
authors.initials: M
authors.lastname: Etherton
authors.forename: Csaba
authors.initials: C
authors.lastname: Földy
authors.forename: Manu
authors.initials: M
authors.lastname: Sharma
authors.forename: Katsuhiko
authors.initials: K
authors.lastname: Tabuchi
authors.forename: Xinran
authors.initials: X
authors.lastname: Liu
authors.forename: Mehrdad
authors.initials: M
authors.lastname: Shamloo
authors.forename: Robert C
authors.initials: RC
authors.lastname: Malenka
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Südhof
mesh_terms: D000818:Animals; D001321:Autistic Disorder / Q000235:genetics; D015816:Cell Adhesion Molecules, Neuronal / Q000235:genetics*; D002540:Cerebral Cortex / Q000502:physiology*; D006624:Hippocampus / Q000502:physiology*; D017774:Long-Term Potentiation / Q000235:genetics; D008565:Membrane Proteins / Q000235:genetics*; D051379:Mice; D008817:Mice, Mutant Strains; D020125:Mutation, Missense / Q000502:physiology; D009419:Nerve Tissue Proteins / Q000235:genetics*; D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; D013569:Synapses / Q000235:genetics / Q000502:physiology; D009435:Synaptic Transmission / Q000235:genetics*
chemical_list: D015816:Cell Adhesion Molecules, Neuronal; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; C098004:neuroligin 3